HOME
SERVICES & PRODUCTS
DIAGNOSTIC REAGENTS
>
ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
CONTROL SERA
DIAGNOSTIC SERVICE
>
BOVINE (AGENTS)
BOVINE (PANELS)
OTHER SPECIES
ANIMAL MODELS
>
MODELS OF NEOSPOROSIS
MODELS OF TOXOPLASMOSIS
MODELS OF CRYPTOSPORIDIOSIS
DRUG SCREENING
TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
R+D+I
DEVELOPMENT OF VACCINES
DIVA VACCINES
IN VITRO AND IN VIVO MODELS & DRUG SCREENING
NEWS
WHO ARE WE?
CONTACT US
ESPAÑOL
MOUSE MODEL
Model developed in non-consanguineous mouse (Mus musculus) strains infected by Toxoplasma gondii oocysts.
Uses: Efficacy of new drugs and vaccines as "proof of concept".
toxoratónmuller_et_al._2017.pdf
File Size:
424 kb
File Type:
pdf
Descargar archivo
FELINE MODEL
Model developed in the definitive host (
Felis silvestris catus
).
Uses: Production of oocysts. Evaluation of drugs and vaccines
.
PREGNANT OVINE MODEL
Model developed in pregnant sheep (
Ovis aries
) based on challenge with oocysts * during the second third of gestation.
Uses: Evaluation of drugs and vaccines.
CONTACT US
By sending the data you accept
our privacy policy
HOME
SERVICES & PRODUCTS
DIAGNOSTIC REAGENTS
>
ANTIGENS AND OTHER DIAGNOSTIC REAGENTS
CONTROL SERA
DIAGNOSTIC SERVICE
>
BOVINE (AGENTS)
BOVINE (PANELS)
OTHER SPECIES
ANIMAL MODELS
>
MODELS OF NEOSPOROSIS
MODELS OF TOXOPLASMOSIS
MODELS OF CRYPTOSPORIDIOSIS
DRUG SCREENING
TECHNICAL ADVICE AND DEVELOPMENT OF NEW PRODUCTS
R+D+I
DEVELOPMENT OF VACCINES
DIVA VACCINES
IN VITRO AND IN VIVO MODELS & DRUG SCREENING
NEWS
WHO ARE WE?
CONTACT US
ESPAÑOL